美国橘皮组织治疗市场规模、份额、趋势分析报告：按治疗程序、橘皮组织、最终用途、细分市场预测，2025-2033 年

美国橘皮组织治疗市场趋势：

美国橘皮组织治疗市场规模预计在 2024 年达到 5.7064 亿美元，预计在 2025 年至 2033 年期间的复合年增长率为 9.7%。人们对化妆品和美容护理的日益增长的偏好以及肥胖率的急剧上升正在推动市场扩张。与肥胖相关的社会和心理挑战，如耻辱感、基于体重的偏见、情绪困扰和自信心下降，已成为主要驱动因素。肥胖者经常遭遇霸凌、社会排斥以及教育和就业机会有限。例如，诺和诺德发表的一篇论文强调，肥胖族群在专业和学术环境中经常受到歧视。这种社会压力对美国对橘皮组织治疗的需求不断增长做出了重大贡献。

微创手术正日益取代侵入性手术。例如，根据美国整形外科医师协会的数据，2023年将实施2,540万例美容微创手术，其中74万例为非侵入性减脂手术。因此，微创手术的日益普及，加上各种微创治疗方案的出现，正在推动美国橘皮组织治疗市场的成长。

久坐不动的生活方式和肥胖率的快速上升显着增加了橘皮组织的盛行率。根据美国疾病管制与预防中心 (CDC) 的数据，近 42% 的美国成年人患有肥胖症，许多州的肥胖率甚至超过 35%。由于过剩的脂肪组织会促进橘皮组织的形成，越来越多的人开始寻求美容治疗。随着人们健康意识的增强和对自我护理的渴望，这一趋势进一步增强，人们对于无需侵入性手术即可获得更光滑、更紧緻肌肤的解决方案的需求也日益增长。

近年来，射频、雷射、超音波、冷冻溶脂以及像 Cellfina 这样的皮下切割技术等非侵入性和微创技术取得了快速创新，这些技术能够有效治疗，并最大程度缩短恢復期。消费者越来越青睐门诊手术以及方便局部/居家治疗方案，这些方案既适合他们繁忙的日程安排，又易于获得。在可支配收入不断增长和直接面向消费者的教育的推动下，这些技术使橘皮组织治疗更加主流且价格合理，从而显着促进了市场扩张。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国橘皮组织治疗市场变数、趋势与范围

• 市场展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国橘皮组织治疗市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析

第四章美国橘皮组织治疗市场：治疗估计与趋势分析

• 步骤细分仪表板
• 美国橘皮组织治疗市场：治疗差异分析
• 美国橘皮组织治疗市场规模和趋势分析（按程序，2021-2033 年）
• 非侵入性治疗
• 微创治疗
• 局部治疗

第五章美国橘皮组织治疗市场：橘皮组织评估与趋势分析

• 橘皮组织细分仪表板
• 美国橘皮组织治疗市场：橘皮组织趋势分析
• 美国橘皮组织治疗市场规模及趋势分析（依橘皮组织，2021-2033）
• 软脂肪团
• 硬脂肪团
• 水肿性橘皮组织

第六章美国橘皮组织治疗市场：最终用途估计与趋势分析

• 2024年及2033年最终用途市场占有率
• 最终用途细分仪表板
• 2021 年至 2033 年按应用分類的市场规模、预测与趋势分析
• 医院
• 诊所及美容中心

第七章 竞争态势

• 主要市场参与企业的近期趋势和影响分析
• 公司/竞争对手分类
• 2024年公司市场占有率分析
• 公司简介/上市公司
  • Merz Pharma
  • Hologic Inc.（Cynosure）
  • Syneron Medical
  • Zimmer Aesthetics
  • Alma Lasers
  • Cymedics
  • Nubway
  • AbbVie
  • Cutera

U.S. Cellulite Treatment Market Trends:

The U.S. cellulite treatment market size was estimated at USD 570.64 million in 2024 and is expected to grow at a CAGR of 9.7% from 2025 to 2033. The growing preference for cosmetic and aesthetic treatments, along with a surge in obesity rates, is propelling market expansion. Social and psychological challenges linked to obesity such as stigma, weight-based prejudice, emotional distress, and reduced self-confidence are emerging as key drivers. Individuals with obesity frequently encounter bullying, social exclusion, and limited access to educational and employment opportunities. For example, a publication by Novo Nordisk highlights that people with obesity are often discriminated against in professional and academic settings. These societal pressures are significantly contributing to the rising demand for cellulite treatment solutions in the U.S.

Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to American Society of Plastic Surgeons, 25.4 million cosmetic minimally-invasive procedures were carried out in 2023, out of which 0.74 million were Non-invasive fat reduction procedures. Thus, increasing adoption of minimally invasive surgeries, coupled with availability of a wide range of minimally invasive treatment options, is driving the growth of the U.S. cellulite treatment market.

A surge in sedentary lifestyles and obesity has significantly increased the prevalence of cellulite. According to the CDC, nearly 42% of U.S. adults were obese, with many states showing obesity rates exceeding 35%. Excess adipose tissue contributes to the development of cellulite, prompting more individuals to seek cosmetic treatments. This trend is further reinforced by growing health consciousness and a desire for self-care, translating into increased demand for solutions that offer smoother, more toned skin even in the absence of invasive surgery.

Recent years have seen rapid innovation in non-invasive and minimally invasive technologies such as radiofrequency, laser, ultrasound, cryolipolysis, and subcision techniques such as Cellfina offering effective results with minimal downtime. Consumers increasingly favor outpatient procedures and topical/home treatment options that align with busy schedules and ease of access. These technologies, supported by rising disposable incomes and direct-to-consumer education, have made cellulite treatments more mainstream and affordable, significantly driving market expansion.

U.S. Cellulite Treatment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cellulite treatment market report on the basis of procedure, cellulite, and end use:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Non-Invasive Treatment
• Minimally Invasive Treatment
• Topical Treatment
• Cellulite Outlook (Revenue, USD Million, 2021 - 2033)
• Soft Cellulite
• Hard Cellulite
• Edematous Cellulite
• End UseOutlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics and Beauty Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. Cellulite
  • 1.2.3. End Use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Procedure outlook
  • 2.2.2. Cellulite outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive scenario

Chapter 3. U.S. Cellulite Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Cellulite Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cellulite Treatment Market: Procedure Estimates & Trend Analysis

• 4.1. Procedure Segment Dashboard
• 4.2. U.S. Cellulite Treatment Market: Procedure Movement Analysis
• 4.3. U.S. Cellulite Treatment Market Size & Trend Analysis, By Procedure, 2021 to 2033 (USD Million)
• 4.4. Non-Invasive Treatment
  • 4.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 4.5. Minimally Invasive Treatment
  • 4.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 4.6. Topical Treatment
  • 4.6.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. U.S. Cellulite Treatment Market: Cellulite Estimates & Trend Analysis

• 5.1. Cellulite Segment Dashboard
• 5.2. U.S. Cellulite Treatment Market: Cellulite Movement Analysis
• 5.3. U.S. cellulite treatment market Size & Trend Analysis, By Cellulite, 2021 to 2033 (USD Million)
• 5.4. Soft Cellulite
  • 5.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 5.5. Hard Cellulite
  • 5.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 5.6. Edematous Cellulite
  • 5.6.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. U.S. Cellulite Treatment Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2024 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, By End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 6.5. Clinics and Beauty Centers
  • 6.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company market share analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Merz Pharma
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Procedure benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Hologic Inc. (Cynosure)
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Procedure benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Syneron Medical
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Procedure benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Zimmer Aesthetics
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Procedure benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Alma Lasers
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Procedure benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Cymedics
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Procedure benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Nubway
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Procedure benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. AbbVie
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Procedure benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Cutera
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Procedure benchmarking
    • 7.4.9.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. cellulite treatment market, by Procedure, 2021 - 2033 (USD Million)
• Table 3 U.S. cellulite treatment market, by Cellulite, 2021 - 2033 (USD Million)
• Table 4 U.S. cellulite treatment market, by End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. Cellulite Treatment Market: market outlook
• Fig. 10 U.S. Cellulite Treatment Market competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. cellulite treatment market driver impact
• Fig. 16 U.S. cellulite treatment market restraint impact
• Fig. 17 U.S. cellulite treatment market strategic initiatives analysis
• Fig. 18 U.S. cellulite treatment market: Procedure movement analysis
• Fig. 19 U.S. cellulite treatment market: Procedure outlook and key takeaways
• Fig. 20 Non-Invasive Treatment market estimates and forecast, 2021 - 2033
• Fig. 21 Minimally Invasive Treatment market estimates and forecast, 2021 - 2033
• Fig. 22 U.S. Cellulite Treatment Market: Cellulite movement analysis
• Fig. 23 U.S. Cellulite Treatment Market: Cellulite outlook and key takeaways
• Fig. 24 Soft Cellulite market estimates and forecast, 2021 - 2033
• Fig. 25 Hard Cellulite market estimates and forecast, 2021 - 2033
• Fig. 26 U.S. Cellulite Treatment Market: End Use movement analysis
• Fig. 27 U.S. Cellulite Treatment Market: End Use outlook and key takeaways
• Fig. 28 Hospitals market estimates and forecast, 2021 - 2033
• Fig. 29 Clinics and Beauty Centers market estimates and forecast, 2021 - 2033